Indobufen

From Wikipedia, the free encyclopedia
Indobufen
Systematic (IUPAC) name
2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid
Clinical data
AHFS/Drugs.com International Drug Names
Legal status ?
Identifiers
CAS number 63610-08-2 YesY
ATC code B01AC10
PubChem CID 107641
ChemSpider 96823 N
UNII 6T9949G4LZ YesY
KEGG D07141 YesY
ChEMBL CHEMBL1765292 N
Chemical data
Formula C18H17NO3 
Mol. mass 295.333 g/mol
 N (what is this?)  (verify)

Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]

References

  1. The Merck Index, 12th Edition. 4991
  2. Eligini, Sonia; Violi, F; Banfi, C; Barbieri, SS; Brambilla, M; Saliola, M; Tremoli, E; Colli, S (2005). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research 69 (1): 218–226. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551. 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.